Bulletin
Investor Alert

Alkermes PLC

NAS: ALKS

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Alkermes PLC

After Hours

ALKS
/zigman2/quotes/205084517/composite

$

27.29

Change

0.00 0.00%

Volume

Volume 57,685

Mar 28, 2023, 4:03 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/205084517/composite

Today's close

$ 27.01

$ 27.29

Change

+0.28 +1.04%

Day low

Day high

$27.00

$27.40

Open
Open: 27.00

52 week low

52 week high

$21.75

$32.79

Open

Market cap

$4.44B

Average volume

1.23M

P/E ratio

N/A

Rev. per Employee

$487,629

EPS

-0.97

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/alks

MarketWatch News on ALKS

  1. Alkermes, Allakos See Activist Action

    9:30 p.m. Oct. 14, 2022

    - Barron's Online

  2. Alkermes upgraded to neutral from underperform at BofA Securities

    9:48 a.m. Oct. 14, 2022

    - Tomi Kilgore

  3. How to Avoid the Biotech Bear Market: Get Some Products Approved

    9:33 p.m. May 13, 2022

    - Barron's Online

  5. Nektar Shares Halve on Cancer Trial Failure

    6:14 p.m. March 14, 2022

    - Barron's Online

  6. Alkermes downgraded to underperform from neutral at BofA Securities

    9:41 a.m. Sept. 2, 2021

    - Tomi Kilgore

  7. Alkermes stock halted for news pending

    7:00 a.m. June 1, 2021

    - Tomi Kilgore

  8. Biotech Is Down. How It Could Come Back.

    9:41 a.m. May 17, 2021

    - Barron's Online

  9. The Case for AbbVie as a Top Biopharma Stock in 2021

    9:45 a.m. Jan. 7, 2021

    - Barron's Online

  10. Alkermes upgraded to buy from neutral at Mizuho

    6:35 a.m. Oct. 15, 2020

    - Tomi Kilgore

  11. Alkermes stock price target raised to $24 from $19 at Mizuho

    6:04 a.m. Oct. 15, 2020

    - Tomi Kilgore

  13. Alkermes downgraded to neutral from buy at BofA Securities

    11:40 a.m. Feb. 14, 2020

    - Tomi Kilgore

  14. Alkermes stock price target cut to $20 from $31 at BofA Securities

    11:40 a.m. Feb. 14, 2020

    - Tomi Kilgore

  15. Alkermes downgraded to neutral from overweight at J.P. Morgan

    8:51 a.m. Feb. 14, 2020

    - Tomi Kilgore

  16. Alkermes stock price target cut to $21 from $25 at J.P. Morgan

    8:52 a.m. Feb. 14, 2020

    - Tomi Kilgore

  17. FDA told Alkermes to stop publishing Vivitrol ad

    1:12 p.m. Dec. 11, 2019

    - Jaimy Lee

  18. Alkermes to acquire Rodin Therapeutics for up to $950 million

    8:30 a.m. Nov. 18, 2019

    - Ciara Linnane

  19. Biogen shares fall 3%

    4:08 p.m. Nov. 14, 2019

    - Jaimy Lee

  21. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/alks

Other News on ALKS

  1. 10-K: ALKERMES PLC.

    5:53 p.m. Feb. 16, 2023

    - Edgar Online - (EDG = 10Q, 10K)

  2. Can Drugs Treat Addiction? Prisons Offer an Answer

    3:34 a.m. Dec. 10, 2022

    - The Wall Street Journal Interactive Edition

  4. How Alkermes (ALKS) Stock Stands Out in a Strong Industry

    9:40 a.m. Nov. 23, 2022

    - Zacks.com

  5. Top 5 3rd Quarter Trades of Meditor Group Ltd

    7:00 p.m. Nov. 7, 2022

    - GuruFocus.com

  7. Alkermes plc 2022 Q3 - Results - Earnings Call Presentation

    1:43 p.m. Nov. 2, 2022

    - Seeking Alpha

  8. Alkermes plc (ALKS) Q3 2022 Earnings Call Transcript

    1:41 p.m. Nov. 2, 2022

    - Seeking Alpha

  9. Alkermes (ALKS) Q3 Earnings Meet Estimates, Revenues Miss

    11:43 a.m. Nov. 2, 2022

    - Zacks.com

  11. 10-Q: ALKERMES PLC.

    9:22 a.m. Nov. 2, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  12. Alkermes (ALKS) Q3 Earnings Match Estimates

    8:35 a.m. Nov. 2, 2022

    - Zacks.com

  14. Notable earnings before Wednesday's open

    10:24 a.m. Nov. 1, 2022

    - Seeking Alpha

  17. EMERALD ADVISERS, LLC Buys 1, Sells 4 in 3rd Quarter

    5:00 p.m. Oct. 25, 2022

    - GuruFocus.com

  18. Acorda wins $16.5M in Ampyra arbitration case with Alkermes

    7:53 a.m. Oct. 17, 2022

    - Seeking Alpha

  21. Loading more headlines...
/news/pressrelease/company/us/alks

Press Releases on ALKS

  2. Alkermes to Participate in the Stifel 2023 CNS Days

    4:00 p.m. March 15, 2023

    - PR Newswire - PRF

  9. Alkermes to Participate in the Stifel Healthcare Conference

    5:00 p.m. Nov. 8, 2022

    - PR Newswire - PRF

  10. Alkermes plc Reports Third Quarter 2022 Financial Results

    7:02 a.m. Nov. 2, 2022

    - PR Newswire - PRF

  11. Alkermes plc Announces Intent to Separate Oncology Business

    7:00 a.m. Nov. 2, 2022

    - PR Newswire - PRF

  13. Alkermes to Report Third Quarter Financial Results on Nov. 2, 2022

    4:01 p.m. Oct. 26, 2022

    - PR Newswire - PRF

  17. Alkermes plc Reports Second Quarter 2022 Financial Results

    7:00 a.m. July 27, 2022

    - PR Newswire - PRF

  18. Alkermes to Report Second Quarter Financial Results on July 27, 2022

    4:00 p.m. July 20, 2022

    - PR Newswire - PRF

  20. Sarissa Capital Comments on Alkermes Annual Meeting

    7:04 a.m. July 6, 2022

    - BusinessWire - BZX

  21. Loading more headlines...

Rates »

Mortgage Equity Savings Auto
Link to MarketWatch's Slice.